Previous Close | 5.20 |
Open | 5.20 |
Bid | 5.25 x N/A |
Ask | 5.40 x N/A |
Day's Range | 5.20 - 5.20 |
52 Week Range | 1.96 - 7.26 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights Significantly high institutional ownership implies Syros Pharmaceuticals' stock price is sensitive to...
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call.
Q1 2024 Syros Pharmaceuticals Inc Earnings Call